Chimeric antigen receptor T-cell therapy is an immunotherapy in which the patient's own T cells are isolated in the laboratory, redirected with a synthetic receptor to recognize a particular antigen or protein, and reinfused into the patient.
Sagar B. Kudchodkar, PhD
Advertisement
Articles by Sagar B. Kudchodkar, PhD
Advertisement
Latest Updated Articles
Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy for Leukemia and BeyondPublished: August 29th 2014 | Updated:
Advertisement
Advertisement
Trending on CGTlive®
1
Tr1X's Multiple Sclerosis Cell Therapy TRX319 Cleared for US Trial
2
Krystal Biotech’s Neurotrophic Keratitis Gene Therapy Viral Vector Secures FDA Platform Technology Designation
3
Around the Helix: Cell and Gene Therapy Company Updates – October 15, 2025
4
